TITLE

Patient preferences and treatment safety for uncomplicated vulvovaginal candidiasis in primary health care

PUB. DATE
January 2011
SOURCE
BMC Public Health;2011, Vol. 11 Issue 1, p63
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Vaginitis is a common complaint in primary care. In uncomplicated candidal vaginitis, there are no differences in effectiveness between oral or vaginal treatment. Some studies describe that the preferred treatment is the oral one, but a Cochrane's review points out inconsistencies associated with the report of the preferred way that limit the use of such data. Risk factors associated with recurrent vulvovaginal candidiasis still remain controversial. Methods/Design: This work describes a protocol of a multicentric prospective observational study with one year follow up, to describe the women's reasons and preferences to choose the way of administration (oral vs topical) in the treatment of not complicated candidal vaginitis. The number of women required is 765, they are chosen by consecutive sampling. All of whom are aged 16 and over with vaginal discharge and/or vaginal pruritus, diagnosed with not complicated vulvovaginitis in Primary Care in Madrid. The main outcome variable is the preferences of the patients in treatment choice; secondary outcome variables are time to symptoms relief and adverse reactions and the frequency of recurrent vulvovaginitis and the risk factors. In the statistical analysis, for the main objective will be descriptive for each of the variables, bivariant analysis and multivariate analysis (logistic regression). The dependent variable being the type of treatment chosen (oral or topical) and the independent, the variables that after bivariant analysis, have been associated to the treatment preference. Discussion: Clinical decisions, recommendations, and practice guidelines must not only attend to the best available evidence, but also to the values and preferences of the informed patient.
ACCESSION #
59753573

 

Related Articles

  • Patient preferences and treatment safety for uncomplicated vulvovaginal candidiasis in primary health care. González, Isabel Del-Cura; González, Francisca García-de-Blas; Cuesta, Teresa Sanz; Fernández, Jesús Martín; Del-Alamo Rodríguez, Justo M.; Ferrairo, Rosa A. Escriva; del Canto De-Hoyos Alonso, M.; Arenas, Laura Balsalobre; Barrientos, Ricardo Rodríguez; Wiesmann, Elisa Ceresuela; De-Alba Romero, Cristina; Díaz, Yolanda Ginés; Rodríguez-Moñino, Ana Pastor; Teira, Blanca Gutiérrez; del Pozo, Marta Sánchez-Celaya; Horcajuel // BMC Public Health;2011, Vol. 11 Issue 1, p63 

    Background: Vaginitis is a common complaint in primary care. In uncomplicated candidal vaginitis, there are no differences in effectiveness between oral or vaginal treatment. Some studies describe that the preferred treatment is the oral one, but a Cochrane's review points out inconsistencies...

  • A Cost-Effective Strategy for Diagnosing Vaginal Candidiasis. WALLING, ANNE D. // American Family Physician;3/1/1999, Vol. 59 Issue 5, p1308 

    Presents an abstract of the study `Vulvovaginal candidiasis: Clinical manifestations, risk factors, management algorithm,' by L. O. Eckert, et al., from the `Obstetrics Gynecology,' dated November 1998.

  • Chronic Vaginal Candidiasis: Management in the Postmenopausal Patient. Nwokolo, N.C.; Boag, F.C. // Drugs & Aging;2000, Vol. 16 Issue 5, p335 

    Vulvovaginal candidiasis (VVC) is a cause of significant morbidity in many women of a childbearing age worldwide. There is a paucity of literature on the prevalence of this condition in postmenopausal women, although it is believed to be uncommon because of the estrogen dependence of VVC....

  • Vulvovaginitis Candidiasis Recurrence During Pregnancy. Fardiazar, Z.; Ronaci, F.; Torab, R.; Goldust, M. // Pakistan Journal of Biological Sciences;4/15/2012, Vol. 15 Issue 8, p399 

    Vulvovaginitis is the most common gynecologic condition seen by practitioners rendering primary care to women. Vulvovaginitis Candidiasis (VVC) is the most common type of vaginitis and this study aimed at specifying VVC recurrence during pregnancy. In this prospective study, 150 pregnant women...

  • Office Laboratory Diagnosis of Vaginitis. Ferris, Daron G.; Hendrich, Julie; Payne, Peter M.; Getts, Alan; Rassekh, Riaz; Mathis, Dianne; Litaker, Mark S. // Journal of Family Practice;Dec1995, Vol. 41 Issue 6, p575 

    This article evaluates routine clinician-performed office laboratory diagnostic techniques for women with abnormal vaginal symptoms. The traditional diagnosis of vaginitis incorporates patient symptoms, clinical findings observed during vaginal examination, and laboratory analysis of vaginal...

  • Treatment of Recurrent Vulvovaginal Candidiasis. Ringdahl, Erika N. // American Family Physician;6/1/2000, Vol. 61 Issue 11, p3306 

    Details the treatment of recurrent vulvovaginal candidiasis. Diagnosis of vulvovaginal candidiasis; Causes of recurrence; Treatment options for recurrent vulvovaginal candidiasis.

  • Subjective health status and health-related quality of life among women with Recurrent Vulvovaginal Candidosis (RVVC) in Europe and the USA. Aballéa, Samuel; Guelfucci, Florent; Wagner, Julian; Khemiri, Amine; Dietz, Jean-Paul; Sobel, Jack; Toumi, Mondher // Health & Quality of Life Outcomes;2013, Vol. 11 Issue 1, p1 

    Background Recurrent vulvovaginal candidosis (RVVC) is a chronic condition causing discomfort and pain. Health status and health-related quality of life (HRQoL) in RVVC were never previously described using validated questionnaires. The objective of this study is to describe subjective health...

  • Prevalence of vulvovaginal candidiasis and frequency of Candida speices in women referred to gynecology obstetrics clinic at Kashan-Iran since 2008 to 2010. Nazeri, Mahdi; Mesdaghinia, Elahe; Moraveji, Seyed Ali Reza; Atabakhshiyan, Roya; Soleymani, Fateme // Journal of Mazandaran University of Medical Sciences (JMUMS);Feb2012, Vol. 22 Issue 86, p261 

    Background and purpose: Vulvovaginal candidiasis (VVC) often referred to as a yeast infection which is a common gynecologic problem, affecting %75 of women during their lifetimes. More than 40% of affected women will have 2 or more VVC episodes. Candida albicans is the most agent of VVC; however...

  • The Evolution of Candida Species and Fluconazole Susceptibility among Oral and Vaginal Isolates Recovered from Human Immunodeficiency Virus (HIV)-Seropositive and At-Risk HIV-Seronegative Women. Sobel, Jack D.; Ohmit, Suzanne E.; Schuman, Paula; Vazquez, Jose A.; Klein, Robert S.; Mayer, Kenneth; Duerr, Ann; Rompalo, Anne // Journal of Infectious Diseases;1/15/2001, Vol. 183 Issue 2, p286 

    Presents a study which identified the oral and vaginal Candida isolates obtained from HIV-seropositive and at-risk HIV-seronegative women for the evaluation of fluconazole susceptibility. Methodology; Population characteristics; Susceptibility to fluconazole among oral and vaginal Candida...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics